Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Orasis Pharmaceuticals

Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.

Overview Structured Data Issues Contributors Activity

orasis-pharma.com

Is a

Organization

Company

Company attributes

Industry

Biomedical engineering

Engineering

Biotechnology

Pharmaceutical industry

Location

B2X

CEO

Number of Employees (Ranges)

11 – 50

Email Address

info@orasis-pharma.com

Full Address

12 Maskit St., Herzlyia, IL

Investors

SBI Japan-Israel Innovation Fund

Visionary Ventures

Maverick Ventures Israel

LifeSci Venture Partners

Bluestem Capital

Sequoia Capital

Marlin Equity Partners

Maverick Ventures

...

Founded Date

2015

Total Funding Amount (USD)

111,000,000

Latest Funding Round Date

October 8, 2024

Latest Funding Type

Series D

Country

Israel

Other attributes

Company Operating Status

Active

Latest Funding Round Amount (USD)

68,000,000

Public/Private

Private

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Orasis Pharmaceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API